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Objectives. A reproducible fetal animal model of single-
ventricle physiology was created to examine the effects of phar-
macologic agents commonly used in the perinatal and periopera-
tive intensive care management of patients with a single ventricle.
Background. Single-ventricle physiology is characterized by
parallel pulmonary and systemic circulations, with effective blood
ﬂow to each determined by the relative resistances in the pulmo-
nary and systemic vascular beds. Perinatal and perioperative
management of these patients is largely based on empiric obser-
vations and differs considerably between institutions and is fur-
ther complicated by the transitional physiology of the newborn.
The lack of animal models of single-ventricle physiology has
hindered the understanding of this problem.
Methods. A 10-mm, Damus-Kaye-Stansel–type aortopulmonary
anastomosis was created in 10 fetal sheep at 140  1.2 days of
gestation. The main pulmonary artery was ligated distally, and
pulmonary blood ﬂow (Qp) was provided through a 5-mm aorto-
pulmonary shunt. Eight lambs were delivered at term and placed
on cardiopulmonary bypass (30 min) 48 to 72 h after birth.
Pharmacologic interventions (0.1 g/kg body weight per min of
epinephrine, 2 mEq/kg of sodium bicarbonate and 10 mg/kg of
calcium chloride) were performed before and after bypass, and
hemodynamic responses were observed. The response to the
epinephrine bolus was determined only in the postbypass study.
Results. Both before and after bypass, epinephrine infusion and
calcium and bicarbonate administration increased Qp and sys-
temic blood ﬂow (Qs) (total cardiac output) but produced only
small changes in the Qp/Qs ratio (0.5% to 7.3% change). With
the epinephrine bolus, Qp increased enormously, and the Qp/Qs
ratio increased by 584% (p < 0.001).
Conclusions. In neonatal lambs with single-ventricle physiology
created in utero, epinephrine infusion and calcium and bicarbon-
ate administration increased total cardiac output without signif-
icantly compromising the Qp/Qs ratio. However, epinephrine
bolus seems to be hemodynamically detrimental in circumstances
of single-ventricle physiology and should be used with caution and
probably in relatively lower doses in the resuscitation of patients
with single-ventricle physiology. Further investigation of the dose-
dependent effects and the effects of prolonged administration of
common pharmacologic agents will enable better management of
patients with single-ventricle physiology.
(J Am Coll Cardiol 1996;28:1877–83)
1996 by the American College of Cardiology
A signiﬁcant proportion of patients born with congenital heart
defects are born with single-ventricle physiology. This includes
not only patients with one functional ventricle but also those
with two ventricles and nonrestrictive communication at the
ventricular or great arterial level. The physiology in these
patients is typically characterized by parallel systemic and
pulmonary circulations, variable mixing of oxygenated and
deoxygenated blood and either excessive or diminished pulmo-
nary blood ﬂow (Qp). Pulmonary and systemic blood ﬂows
(Qs) are determined by the relative resistances in the respec-
tive vascular beds. The distribution of ﬂow to the pulmonary
and systemic circulations affects systemic arterial oxygen satu-
ration and delivery (1). The management of these patients is
focused on achieving a critical balance between Qp and Qs to
promote adequate systemic oxygen delivery without undue
volume overload on the single ventricle. To achieve this critical
balance, a variety of ventilatory adjustments and pharmaco-
logic agents are commonly used (1,2). However, considerable
controversy exists because decisions are often based on an
individual’s institutional experiences (3–5), which are often
derived from the monitoring of physiologic variables that only
indirectly reﬂect the changes in the systemic pulmonary resis-
tance (SVR) and pulmonary vascular resistance (PVR). In
addition, other physiologic effects of altering the PVR/SVR
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ratio, such as absolute systemic output, coronary reserve and
ventricular mechanics, are often given little importance. The
purposes of this study were to establish a reliable fetal animal
model of single-ventricle physiology and to study the effects of
commonly used pharmacologic agents in the perinatal and
perioperative periods.
Methods
Surgical preparation and care. Ewes and fetuses. Ten
mixed-breed Western ewes (140  1.2 days’ gestation, term
145 days) were operated on under sterile conditions with the
use of local anesthesia (2% lidocaine hydrochloride), epidural
anesthesia (4 ml of 1% tetracaine hydrochloride) and intrave-
nous sedation (50 to 100 mg ketamine hydrochloride). After an
18-gauge angiocath was inserted into the maternal jugular vein,
a midline incision was made in the ventral abdomen, and the
pregnant horn of the uterus was exposed. Through a small
uterine incision, the left fetal forelimb and chest were exposed,
and a left lateral thoracotomy was performed in the third
intercostal space. Fetal anesthesia consisted of local anesthesia
with 1% lidocaine hydrochloride and ketamine hydrochloride
(20 mg intramuscularly). Succinylcholine hydrochloride (3 to
5 mg intramuscularly) was administered to prevent fetal
breathing movements. The pericardium was incised along the
main pulmonary trunk and suspended with tacking sutures
(Fig. 1A). The brachiocephalic arterial trunk, ascending aorta
and main pulmonary arteries were dissected and controlled
with vessel loops (Fig. 1B). A Damus-Kaye-Stansel type of
aortopulmonary anastomosis was performed in the following
manner: The ascending aorta was side clamped with a side-
biting vascular clamp. An aortotomy was performed with a no.
11 bladed knife. The aortotomy was extended to 10 mm with
ﬁne scissors, and a strip of aortic wall was excised to create an
oval opening in the ascending aorta. One end of a 5-mm
extended polytetraﬂuoroethylene (ePTFE) vascular graft
(W.L. Gore and Associates) was partially anastomosed side to
side to the end of a 10-mm ePTFE vascular graft (10 mm in
length) to reduce operative suturing (Fig. 1). These were then
anastomosed end to side to the ascending aorta (Fig. 1C). Both
anastomoses were performed with 7.0 prolene suture (Ethicon
Inc.) using a continuous suture technique. Vascular clips were
placed to occlude the grafts temporarily, and the vascular
clamp was released gradually to minimize any bleeding at the
suture line. A side-biting vascular clamp was then applied to
the main pulmonary artery. A pulmonary arteriotomy was
performed, and a strip of the posterior pulmonary artery wall
was excised. The free end of the 10-mm graft was anastomosed
end to side to the opening created in the pulmonary artery.
The vascular clamp was gradually released, allowing any air in
the graft to escape through the suture line and needle holes.
The free end of the 5-mm graft was then anastomosed end to
Abbreviations and Acronyms
ANOVA  analysis of variance
CBP  cardiopulmonary bypass
ePTFE  polytetraﬂuoroethylene
PAP  pulmonary artery pressure
PVR  pulmonary vascular resistance
Qp  pulmonary blood ﬂow
Qs  systemic blood ﬂow
SAP  systemic arterial pressure
SVR  systemic vascular resistance
Figure 1. Surgical technique for in utero cre-
ation of Damus-Kaye-Stansel anastomosis to
achieve single-ventricle physiology. A, Surgical
exposure and anatomy of the ascending aorta
(Ao), descending aorta (DAo), brachiocephalic
trunk (BT), ductus arteriosus (DA), main pul-
monary artery (PA) and left pulmonary artery
(LPA). B, Locations of aortotomy and main
and left pulmonary arteriotomy incisions, as
indicated by the dotted lines. Grafts, Five- and
10-mm extended polytetraﬂuoroethylene grafts
are connected side to side at the rims to reduce
the time required for operative anastomosis. C,
End to side anastomosis of the 5- and 10-mm
grafts to the aortotomy incision with running
sutures. D, Final appearance of the Damus-
Kaye-Stansel anastomosis; clip occlusion of the
main pulmonary artery; and 5-mm aorta to left
pulmonary artery shunt.
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side to an incision made in the left pulmonary artery, providing
a source of pulmonary blood ﬂow (Fig. 1D). The vascular clips
on the grafts were then removed to establish graft patency. The
main pulmonary artery was completely occluded distal to the
Damus anastomosis using a large vascular clip. The thoracot-
omy incision was then closed in layers. Warm saline was
infused to replace the lost amniotic ﬂuid, and the uterine
incision was closed. After recovery from anesthesia, the ewe
was returned to the cage with free access to food and water.
Antibiotics (2 million U of penicillin G procaine and 100 mg of
gentamicin sulfate) were administered intravenously to the
ewe during the operation and daily thereafter for 2 more days.
Lambs. After eight spontaneous deliveries (two fetuses
aborted), antibiotics (1 million U of penicillin G procaine and
25 mg of gentamicin sulfate intramuscularly) were adminis-
tered for 2 days. At 48 to 72 h after birth, eight lambs had
18-gauge polyvinyl catheters placed in an artery and vein of
one hind leg under local anesthesia with 1% lidocaine hydro-
chloride, and the catheters were advanced to the descending
aorta and the inferior vena cava, respectively. The lambs were
then anesthetized with ketamine hydrochloride (1 mg/kg
body weight per min), intubated with a 4.0-mm (outside
diameter) endotracheal tube and mechanically ventilated with
a Healthdyne pediatric time-cycled, pressure-limited ventilator
(Healthdyne Inc.). Pavulon (pancuronium bromide) was ad-
ministered by continuous infusion (0.1 mg/kg intravenously).
Ventilation with room air (fraction of inspired oxygen 0.21)
was adjusted to maintain an arterial partial pressure of carbon
dioxide between 35 and 40 mm Hg. A midsternotomy incision
was performed and the pericardium was incised. The patent
ductus arteriosus was dissected and occluded with a vascular
clip. Two single-lumen polyurethane catheters (20 gauge) were
inserted, one each, into the left and right atria. A single-lumen
polyurethane catheter (20 gauge) was placed in the right
pulmonary artery. An ultrasound ﬂow probe (Transonic Sys-
tems Inc.) was placed around the 5-mm graft (shunt) to
continuously monitor Qp. Ultrasound ﬂow probes were also
placed on the brachiocephalic trunk and the aortic arch for
continuous monitoring of Qs.
Measurements. Pulmonary and systemic arterial and right
and left atrial pressures were measured using Statham P23Db
pressure transducers (Statham Instruments, Hato Rey, PR).
Mean pressures were obtained by electrical integration. Heart
rate was measured by a cardiotachometer triggered from the
phasic systemic arterial pressure pulse wave. Qp and Qs were
measured with an ultrasound ﬂow meter (Transonic Systems
Inc.). All hemodynamic variables were continuously recorded
on a Gould multichannel electrostatic recorder (Gould Inc.).
Blood gases and pH were measured by a Corning 158 pH/
blood gas analyzer (Corning Medical and Scientiﬁc). Hemo-
globin concentration and oxygen saturation were measured by
a hemoximeter (model OSM 2, Radiometer, Copenhagen,
Denmark). PVR and SVR were calculated using standard
formulas. Total cardiac output is calculated as the sum of Qs
and Qp (coronary blood ﬂow is not accounted for with this
technique using ﬂow probes).
Experimental protocol. Hemodynamic study. After a 30-
min recovery period after instrumentation baseline measure-
ments of the hemodynamic variables—pulmonary and systemic
arterial pressure, left and right atrial pressures, heart rate, Qp
and Qs—systemic arterial blood gases were obtained. The
following pharmacologic agents were then administered in
random order and their effects were noted. Sodium bicarbon-
ate (“bicarbonate”; 2 mEq/kg) was administered into the right
atrium as a bolus given over 1 min. The hemodynamic variables
were measured continuously. The maximal hemodynamic ef-
fects after bicarbonate administration, which generally oc-
curred within 2 min, were recorded as the postbicarbonate
infusion values. Systemic arterial blood gases and pH were
measured at the same time. After a 30-min recovery period, all
measurements were repeated and calcium chloride (“calcium”;
10 mg/kg) was administered into the right atrium as a bolus
given over 1 min. Hemodynamic variables were measured
continuously. Maximal hemodynamic effects after calcium
administration, which generally occurred within 2 min, were
recorded for analysis as the postcalcium infusion values. Sys-
temic arterial blood gases and pH were also checked simulta-
neously. After 30 min, all measurements were obtained again,
and epinephrine infusion was started at 0.1 g/kg per min in
the right atrium. After 10 min a new steady state was achieved
and all the measurements were repeated and recorded as
postepinephrine infusion values. Epinephrine infusion was
stopped, and after a waiting period of 30 min, all measure-
ments were repeated and the lambs were placed on cardiopul-
monary bypass (CPB). On CPB the lambs were cooled to 15C,
and circulatory arrest was established for 30 min to mimic a
stage I Norwood procedure. The lambs were then rewarmed
fully and removed from CPB. After a 60-minute recovery
period, all hemodynamic measurements, systemic arterial
blood gases and pH levels were obtained and a stable state was
established. The interventions (bicarbonate, calcium and epi-
nephrine infusion in random order) were repeated, and pre-
infusion and postinfusion values were recorded in the same
manner as before bypass. In addition, after hemodynamic
values were recorded and systemic arterial blood gases and pH
were measured to assess hemodynamic stability, an epineph-
rine bolus (0.05 ml/kg, 1:10,000 vol) was administered as the
last intervention. Hemodynamic variables were continuously
monitored and systemic arterial blood gases were checked
5 min after the bolus. The maximal effects, which generally
occurred soon after administration, were recorded for analysis
as postepinephrine bolus values. At the end of the study, the
lambs were given a lethal dose of pentobarbital sodium. An
autopsy was performed to conﬁrm the placement of intravas-
cular catheters and shunt patency.
The experimental protocol was approved by the Committee
on Animal Research of the University of California, San
Francisco. All animals received humane care in compliance
with the “Principles of Laboratory Animal Care” formulated
by the National Society of Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared by the
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National Academy of Sciences and published by the National
Institutes of Health.
Statistical analysis. Data are expressed as mean value 
SD. The signiﬁcance of changes in hemodynamic variables
produced by drug administration was analyzed by the paired
two-tailed t test. Comparisons between drugs and before and
after bypass for each variable were made using repeated
measures analysis of variance (ANOVA) for the seven surviv-
ing animals. The post hoc test used was the Student-Newman-
Keuls test. Unless stated otherwise, interaction terms were not
signiﬁcant. For analysis of the hemodynamic effects of epi-
nephrine bolus, which was administered only after bypass, the
paired two-tailed t test was performed. SPSS for Windows
version 6.0 (SPSS Inc.) was used for all statistical analyses.
Values of p  0.05 were considered signiﬁcant.
Results
All animals remained hemodynamically stable during pre-
bypass study, and hemodynamic data were obtained and
analyzed in all eight animals. However, during bypass, the
study was discontinued in one animal owing to accidental
massive air embolism. The other seven animals were hemody-
namically stable throughout the bypass and postbypass periods,
and hemodynamic data were available for all seven animals.
Prebypass changes after infusion of epinephrine, bicarbonate
and calcium were calculated from the data for all eight
animals, whereas postbypass statistics reﬂect data for the seven
surviving animals. Repeated measures ANOVA was per-
formed using only the seven surviving animals. Prebypass and
postbypass hemodynamic data in response to epinephrine
infusion, bicarbonate and calcium are summarized in Table 1.
Hemodynamic responses to epinephrine bolus after bypass are
depicted in Figure 2.
Pulmonary artery pressure (PAP). Epinephrine infusion
before bypass resulted in a signiﬁcant rise in PAP. Epinephrine
infusion after bypass led to an insigniﬁcant rise in PAP.
Bicarbonate and calcium administration led to small, insignif-
icant rises in PAP both before and after bypass. An epineph-
rine bolus after bypass produced a 76% increase in PAP (p 
0.0001).
Systemic arterial pressure (SAP). The effects on SAP of
prebypass and postbypass epinephrine infusion, bicarbonate
and calcium are shown in Figure 3. Both before and after
bypass, epinephrine infusion, bicarbonate and calcium pro-
duced signiﬁcant increases in SAP. The postbypass increase
was greater for epinephrine and calcium and less pronounced
for bicarbonate, but none of these differences were signiﬁcant.
Repeated measures ANOVA interactions approached signiﬁ-
cance (p 0.08). The postbypass epinephrine bolus resulted in
a sudden and signiﬁcant 152% increase in SAP (p  0.0001).
Indexed pulmonary blood ﬂow. Prebypass and postbypass
effects of epinephrine infusion, bicarbonate and calcium on Qp
are shown in Figure 4. Epinephrine infusion, bicarbonate and





















Pre-epi 29.0  7.4 59.5  12.4 262  40 145  35 1.93  0.69 0.088  0.026 0.39  0.14
Post-epi 31.3  6.0* 64.3  12.4† 298  56‡ 173  38§ 1.82  0.64 0.085  0.020 0.35  0.11
After bypass
Pre-epi 28.6  6.0 50.9  9.9 238  60 171  46 1.48  0.54 0.098  0.025 0.28  0.13
Post-epi 29.7  5.6 57.1  8.8† 267  54‡ 195  49† 1.47  0.55 0.091  0.019* 0.28  0.11
Sodium bicarbonate (bicarb)
Before bypass
Pre-bicarb 32.3  5.6 60.0  9.7 252  46 131  28 2.04  0.80 0.106  0.032 0.44  0.13
Post-bicarb 32.6  5.5 66.9  14.0* 276  59* 149  36 2.02  1.0 0.093  0.027* 0.44  0.17
After bypass
Pre-bicarb 28.9  4.0 52.7  10.4 237  62 165  45 1.55  0.64 0.103  0.026 0.31  0.15
Post-bicarb 29.1  4.6 56.3  11.7 260  61§ 191  48§ 1.45  0.47* 0.083  0.020† 0.28  0.13*
Calcium chloride (calcium)
Before bypass
Pre-calcium 31.7  5.4 55.5  11.6 249  30 130  39 2.09  0.80 0.108  0.031 0.41  0.15
Post-calcium 32.0  5.4 59.0  12.5† 268  26† 150  41§ 1.90  0.58* 0.100  0.025 0.38  0.14*
After bypass
Pre-calcium 28.6  4.4 51.7  8.8 238  55 149  49 1.71  0.55 0.101  0.027 0.34  0.14
Post-calcium 28.9  4.0 58.0  7.8* 268  62† 174  50§ 1.60  0.44 0.090  0.025† 0.32  0.11
*p  0.05, †p  0.001, ‡p  0.005, §p  0.0001, p  0.01, relative to preadministration values. Data presented are mean values  SD. PAP  pulmonary artery
pressure; PVR  pulmonary vascular resistance; Qp  indexed pulmonary blood ﬂow; Qp/Qs  pulmonary/systemic blood ﬂow ratio; Qs  indexed systemic blood
ﬂow; SAP  systemic arterial pressure; SVR  systemic vascular resistance.
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calcium all led to signiﬁcant increases in Qp both before and
after bypass. Notably, the postbypass effect of calcium was
signiﬁcantly greater than the prebypass effect. Repeated mea-
sures ANOVA interactions approached signiﬁcance (p 
0.09). The epinephrine bolus after bypass increased Qp by 94%
(p  0.0001).
Indexed systemic blood ﬂow. Prebypass and postbypass
effects of epinephrine infusion, bicarbonate and calcium on Qs
are depicted in Figure 5. Epinephrine infusion, bicarbonate
and calcium all produced signiﬁcant rises in Qs before and
after bypass. The prebypass and postbypass effects did not
differ signiﬁcantly for any of these agents. Systemic blood ﬂow
fell signiﬁcantly after the postbypass epinephrine bolus (p 
0.0005).
Pulmonary/systemic blood ﬂow ratio (Qp/Qs). The Qp/Qs
ratio decreased slightly after prebypass and postbypass epi-
nephrine infusion, bicarbonate and calcium. Only in the case of
postbypass bicarbonate administration was this decrease sig-
niﬁcant. The postbypass epinephrine bolus produced an in-
crease of 584% in Qp:Qs (p  0.001).
Pulmonary vascular resistance. Epinephrine infusion, bi-
carbonate and calcium all produced insigniﬁcant decreases in
PVR before bypass and signiﬁcant decreases in PVR after
bypass. The difference between prebypass and postbypass
Figure 2. Mean (SD) percent change from baseline in PAP, SAP,
left atrial pressure (LAP), right atrial pressure (RAP), indexed Qp,
indexed Qs, Qp/Qs ratio, SVR and PVR/SVR ratio after postbypass
epinephrine bolus injection. *p  0.0001; †p  0.001; ‡p  0.0005;
§p  0.005.
Figure 3. Mean (SD) percent change in SAP after epinephrine
infusion and administration of bicarbonate and calcium before (n  8
[solid bars]) and after (n 7 [open bars]) CBP. †p 0.001; $p 0.05;
‡p  0.01; §p  0.005.
Figure 4. Mean (SD) percent change in indexed Qp after epineph-
rine infusion and administration of bicarbonate and calcium before
(n  8 [solid bars]) and after (n  7 [open bars]) CPB. §p  0.005;
$p  0.05; *p  0.0001; †p  0.001.
Figure 5. Mean (SD) percent change in indexed Qs after epineph-
rine infusion and administration of bicarbonate and calcium before
(n  8 [solid bars]) and after (n  7 [open bars]) CPB. *p  0.0001;
†p  0.001; ‡p  0.01.
1881JACC Vol. 28, No. 7 REDDY ET AL.
December 1996:1877–83 FETAL MODEL OF SINGLE-VENTRICLE PHYSIOLOGY
changes was not signiﬁcant with any of these agents. Epineph-
rine bolus after bypass lowered PVR by 18% (p  0.028).
Systemic vascular resistance. Prebypass and postbypass
epinephrine infusion led to an insigniﬁcant decrease in SVR.
The SVR changed negligibly after prebypass bicarbonate ad-
ministration, but decreased signiﬁcantly after postbypass bicar-
bonate. Calcium produced a signiﬁcant decrease in SVR
before bypass and an insigniﬁcant decrease in SVR after
bypass. The epinephrine bolus after bypass increased SVR by
856% (p  0.0005).
Discussion
Background. Infants born with congenital heart defects
that result in functional single-ventricle physiology are often
difﬁcult to manage in the neonatal and postoperative periods.
Congenital anomalies characterized by single ventricle physi-
ology, which include a single right ventricle, a single left
ventricle, tricuspid atresia, a double-outlet right ventricle and
hypoplastic left heart syndrome, share the common trait of
pulmonary and systemic circulations that are perfused in parallel
rather than in series. The balance between Qp and Qs in such
circumstances depends primarily on the relative resistances in
the pulmonary and systemic vascular beds (1). The absolute
and relative volumes of Qp and Qs, in turn, determine the
clinical presentation of various single ventricle types of con-
genital heart defects. If Qp is markedly increased, systemic
hypoperfusion and metabolic acidosis develop, whereas re-
duced Qp results in hypoxemia and cyanosis despite adequate
systemic perfusion. Increased Qp in certain subgroups of
neonates can also lead to a progressive volume overload on the
single ventricle, congestive heart failure and elevation in PVR.
Thus, a careful balance between Qp and Qs must be main-
tained to preserve sufﬁcient arterial oxygen saturation without
overloading the single ventricle (1,2). Imbalance in either
direction can be lethal, especially during times when these
resistances are typically in ﬂux.
Two speciﬁc settings in which the pulmonary and systemic
resistance beds change dramatically are during the period of
early neonatal transitional physiology and after CPB used
during surgical palliation for these infants. Various respiratory
and pharmacologic interventions are often used in efforts to
achieve a critical balance between Qp and Qs. Management
approaches to these patients are controversial and vary con-
siderably from one institution to another, largely on the basis
of experience and empiric observations (2–5). The infant,
meanwhile, remains a physiologic “black box.”
Very few experimental studies have been carried out to
substantiate or refute the current clinical practices. One exper-
imental study (6) has yielded important information. However,
the model employed was created acutely and beyond the
period of transitional physiology, which means that the animals
studied had normal cardiovascular physiology for a period of
time before surgical creation of single ventricle physiology.
Other investigators (7) have reported a mathetical model that
is based on numerous assumptions. Although these studies
have and may continue to provide important information, the
fact that they were created acutely and beyond the period of
transitional physiology must be seen as an important inherent
limitation. The present model, in contrast, is created in utero,
and is therefore not an acutely stressed model. In addition, the
single-ventricle physiology is present from the time of birth,
unlike previous models, which had a period of normal circu-
lation for a few weeks.
Findings with a new experimental model. Although the
cardiac and vascular effects of epinephrine, bicarbonate and
calcium are well known in the normal circulation (8–10), there
is no information on the hemodynamic effects of these phar-
macologic interventions in the setting of single-ventricle phys-
iology. In the present study, the hemodynamic effects of
pharmacologic agents commonly used in the critical care
setting were evaluated in the early neonatal period and after
CPB. As anticipated, epinephrine infusion increased cardiac
output, resulting in rises in absolute Qp and Qs. However, the
Qp/Qs ratio did not change signiﬁcantly before or after bypass.
Calculated SVR and PVR decreased with epinephrine infu-
sion. The decrease in SVR is consistent with the fact that
epinephrine in low doses acts predominantly on beta2 recep-
tors and dilates the skeletal muscle vasculature. However, the
changes in calculated SVR and PVR may, in part, be due to the
increase in Qp and Qs from the positive inotropic effect of
epinephrine (9,10). Epinephrine infusion does not appear to
cause any major imbalance in the Qp/Qs ratio, but further
studies are needed to clarify its dose-dependent effects.
Sodium bicarbonate administration also increased the ab-
solute Qp and Qs and decreased PVR and SVR both before
and after bypass, with minor changes in the Qp/Qs ratio. The
changes produced by bicarbonate are probably due to the
direct effects on the vascular smooth muscle in response to
the pH alteration. The effects of calcium were similar to
bicarbonate, but are more likely due to increased cardiac
output from the positive inotropic effect of calcium on the
ventricular muscle. Further evaluation of dose-responsive he-
modynamic effects of calcium and bicarbonate will be of
importance in the management of patients with single-
ventricle physiology.
The ﬁnding of most concern in this study is the massive
increase in SVR and the tremendous increase in Qp resulting
from the epinephrine bolus. The extreme imbalance in the
Qp/Qs ratio (Fig. 2), caused by even half the code dose (we
gave 0.05 ml/kg) of epinephrine, suggests that boluses of
epinephrine should be used cautiously and in reduced amounts
in the management of patients with single-ventricle physiology.
Study limitations. The present model has two drawbacks:
1) There are two ventricles pumping into the aorta. 2) Mixing
occurs in the aorta, thereby resulting in streaming. Neverthe-
less, the strength of the model lies in the fact that the most
important feature of single-ventricle physiology, namely, par-
allel systemic and pulmonary circulations with shunt-
dependent Qp, is present from birth.
Another critique of this study is that all pharmacologic
interventions were performed in stable animals. This is unre-
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alistic from a clinical point of view, because the pharmacologic
interventions studied are only performed in unstable patients
or in those who have a low cardiac output, or when there is an
imbalance of Qp and Qs. However, the data from this study
provide useful information on commonly used pharmacologic
agents.
Conclusions. This fetal-neonatal model closely mimics the
single ventricle physiology seen in neonates born with various
commonly occurring lesions. An adequate understanding of
single-ventricle physiology during the transitional phase of
circulation has great relevance to the management of many
neonates with congenital heart defects, who almost always
need therapeutic intervention during the ﬁrst few hours to few
days of life. Therefore, this model provides a tool for investi-
gating the mechanisms behind hemodynamic changes during
the transitional phase and perioperative period, and allows for
the evaluation of various means of manipulating PVR and
SVR to achieve a critical balance between Qp and Qs.
Epinephrine infusion and calcium and bicarbonate administra-
tion increase total cardiac output without a signiﬁcant change
in the Qp/Qs ratio. However, an epinephrine bolus appears to
be hemodynamically detrimental in circumstances of single
ventricle physiology. An epinephrine bolus should be used with
caution in the resuscitation of patients with single-ventricle
physiology and probably in smaller doses than usual in patients
with normal circulation. Further investigation to study the
dose-dependent effects as well as the effects of prolonged
administration of common pharmacologic agents used in the
management of patients with single-ventricle physiology is
warranted.
We thank Julien I. E. Hoffman, MD, for scientiﬁc and statistical consultation.
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